Atrial Fibrillation (A-Fib)
Atrial Fibrillation (A-Fib)
David Ray Velez, MD
An Irregular Rhythm that Originates from Ectopic Foci in the Atrium (The Most Common Cardiac Arrhythmia)
EKG Pattern
- RR-Interval with No Regular Pattern (“Irregularly Irregular”)
- No Distinct P Waves
Atrial Fibrillation
Ectopic Foci
- Pulmonary Veins – Most Common
- Right Atrium
- Superior Vena Cava
- Coronary Sinus
Classification
- Paroxysmal: Resolves Spontaneously
- Recurrent: ≥ 2 Episodes
- Persistent: Present for ≥ 7 Days
- Permanent: Present for ≥ One Year
Causes
- Fluid Overload – The Most Common Cause Postop
- Electrolyte Derangements
- Catecholamine Excess (Stress, Thyrotoxicosis, Epinephrine)
- Atrial Distention (Pulmonary Hypertension, Pulmonary Embolism, Mitral Stenosis)
- Ischemic Heart Disease
- Hypothermia
- Alcohol Abuse
- Caffeine Use
Complications
- Impaired Atrial Systolic Function (“Atrial Kick”) – Decreased Ventricular Filling
- Increases Risk for Thromboembolism Formation within the Left Atrium
- Risk for Stroke or Other Ischemic Events
Acute Treatment
- Unstable: Synchronized Cardioversion (Start with 100 J and Increase to 150 J if Fails)
- Stable: Rate Control Preferred Over Rhythm Control
- Treat Any Underlying Causes and Correct Any Electrolyte Derangements
- Heart Rate Goals:
- Chronic Setting: < 110 bpm
- Acute Setting: < 110-120 bpm (Less Well Defined)
Medications and Dosing
- Metoprolol (β-Blockers)
- Generally Preferred in Hyperadrenergic States (Acute MI or Postop)
- Contraindicated in COPD or CHF
- Dosing: 5 mg Every 5-10 Minutes as Needed (Maximum of 3 Doses)
- May Also Consider Esmolol Drip if Necessary
- Diltiazem (Calcium Channel Blocker/CCB)
- Generally Superior to Amiodarone
- Dosing:
- Bolus: 0.25 mg/kg and Repeat a Second Bolus of 0.35 mg/kg After 15 Minutes if Needed
- Continuous Infusion: 5-15 mg/hr
- Amiodarone (Potassium Blocker)
- Favored Agent in Concomitant Heart Failure
- IV Dosing:
- Initial Bolus: 150 mg Bolus and Repeat if Necessary
- Continuous Infusion: 1 mg/min for 6 Hours, then 0.5 mg/min
- Transition to Oral Amiodarone:
- < 1 Week IV Treatment: Oral 800-1,600 mg Daily (Divided Doses)
- 1-3 Weeks IV Treatment: Oral 600-800 mg Daily
- ≥ 3 Weeks IV Treatment: Oral 400 mg Daily
- Digoxin
- Only Used as an Adjunct
- Slow Acting and Not Used as the Sole Therapy
- *See Antiarrhythmic Pharmacology
Anticoagulation Indications
- Persistent > 48 Hours
- If Cardioversion Required
- CHADS-VASC Score ≥ 1-2
- CHF History (+1)
- HTN History (+1)
- Age ≥ 65 (+1) or ≥ 75 (+2)
- DM History (+1)
- Stroke/TIA/Thromboembolism History (+2)
- Vascular Disease History (MI, PAD or Aortic Plaque) (+1)
- Sex Female (+1)